Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marta Ligero"'
Autor:
Marta Ligero, Bente Gielen, Victor Navarro, Pablo Cresta Morgado, Olivia Prior, Rodrigo Dienstmann, Paolo Nuciforo, Stefano Trebeschi, Regina Beets-Tan, Evis Sala, Elena Garralda, Raquel Perez-Lopez
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract The search for understanding immunotherapy response has sparked interest in diverse areas of oncology, with artificial intelligence (AI) and radiomics emerging as promising tools, capable of gathering large amounts of information to identify
Externí odkaz:
https://doaj.org/article/49b9928b68a74233b3c504afa90ca7b9
Autor:
Marta Ligero, Marc Simó, Cecilia Carpio, Gloria Iacoboni, Maria Balaguer‐Montero, Victor Navarro, Mario Andres Sánchez‐Salinas, Sabela Bobillo, Ana Marín‐Niebla, Josu Iraola‐Truchuelo, Pau Abrisqueta, Roser Sala‐Llonch, Francesc Bosch, Raquel Perez‐Lopez, Pere Barba
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1081-1088 (2023)
Abstract Chimeric antigen receptor (CAR) T‐cell therapy is a promising treatment option for relapsed or refractory (R/R) large B‐cell lymphoma (LBCL). However, only a subset of patients will present long‐term benefit. In this study, we explored
Externí odkaz:
https://doaj.org/article/462a685cd00d42bab3c5166896577a04
Autor:
Kinga Bernatowicz, Francesco Grussu, Marta Ligero, Alonso Garcia, Eric Delgado, Raquel Perez-Lopez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Tumor heterogeneity has been postulated as a hallmark of treatment resistance and a cure constraint in cancer patients. Conventional quantitative medical imaging (radiomics) can be extended to computing voxel-wise features and aggregating tu
Externí odkaz:
https://doaj.org/article/5b3a1112d8e04a3e9191a23fcc6fdbe4
Autor:
Alonso Garcia-Ruiz, Pablo Naval-Baudin, Marta Ligero, Albert Pons-Escoda, Jordi Bruna, Gerard Plans, Nahum Calvo, Monica Cos, Carles Majós, Raquel Perez-Lopez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Glioblastoma is the most common primary brain tumor. Standard therapy consists of maximum safe resection combined with adjuvant radiochemotherapy followed by chemotherapy with temozolomide, however prognosis is extremely poor. Assessment of
Externí odkaz:
https://doaj.org/article/8bd6ad5684ac4d938d88553a2be568f0
Autor:
Marta Ligero, Jorge Hernando, Eric Delgado, Alonso Garcia-Ruiz, Xavier Merino-Casabiel, Toni Ibrahim, Nicola Fazio, Carlos Lopez, Alexandre Teulé, Juan W. Valle, Salvatore Tafuto, Ana Custodio, Nicholas Reed, Markus Raderer, Enrique Grande, Rocio Garcia-Carbonero, Paula Jimenez-Fonseca, Alejandro Garcia-Alvarez, Manuel Escobar, Oriol Casanovas, Jaume Capdevila, Raquel Perez-Lopez
Background More accurate predictive biomarkers in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are needed. This study aims to investigate radiomics-based tumour phenotypes as a surrogate biomarker of the tumour vasculature a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82d4ea1b86e871ed3036ce3b72d5c859
https://doi.org/10.21203/rs.3.rs-2647664/v1
https://doi.org/10.21203/rs.3.rs-2647664/v1
Autor:
Alonso Garcia-Ruiz, Albert Pons-Escoda, Francesco Grussu, Pablo Naval-Baudin, Camilo Monreal-Aguero, Gretchen Hermann, Roshan Karunamuni, Marta Ligero, Antonio Lopez-Rueda, Laura Oleaga, Alvaro Berbis, Teodoro Martin-Noguerol, Antonio Luna-Alcala, Tyler Seiber, Carlos Majos, Raquel Perez-Lopez
Non-invasive differential diagnosis of brain tumours is currently based on the assessment of tumour vascularity through magnetic resonance imaging (MRI) coupled with dynamic susceptibility contrast (DSC). However, given its limited accuracy, reaching
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a779f673d742d682744241d0307f1dee
https://doi.org/10.21203/rs.3.rs-2362207/v1
https://doi.org/10.21203/rs.3.rs-2362207/v1
Autor:
Raquel Perez-Lopez, Eric Delgado, Marta Ligero, Francesco Grussu, Alonso Garcia, K. Bernatowicz
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientia
Scientific Reports
Scientia
Scientific Reports
Enginyeria Biomèdica; Imatge del càncer Biomedical engineering; Cancer imaging Ingeniería Biomédica; Imágenes del cáncer Tumor heterogeneity has been postulated as a hallmark of treatment resistance and a cure constraint in cancer patients. Con
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Immunotherapy by immune checkpoint inhibitors has become a standard treatment strategy for many types of solid tumors. However, the majority of patients with cancer will not respond, and predicting response to this therapy is still a challenge. Artif
Autor:
Jaid Landa, Cinta Hierro, Eva Muñoz-Couselo, Paolo Nuciforo, Joan Seoane, Cristina Viaplana, Joaquín Mateo, Marta Ligero, Ignacio Matos, Enriqueta Felip, Debora Gil, Elena Elez, Guillermo Villacampa, Carlota Rubio-Perez, Rodrigo Dienstmann, Joan Carles, Ana Oaknin, Elena Garralda, Josep Tabernero, Macarena Gonzalez, Raquel Perez-Lopez, Maria Ochoa-De-Olza, Juan Martin-Liberal, Alonso Garcia-Ruiz, Manuel Escobar, Cristina Suarez, Maria Vittoria Raciti, Rafael Morales-Barrera, Irene Brana, Roberta Fasani, Jordi Rodon
Publikováno v:
Radiology
Background Reliable predictive imaging markers of response to immune checkpoint inhibitors are needed. Purpose To develop and validate a pretreatment CT-based radiomics signature to predict response to immune checkpoint inhibitors in advanced solid t
Autor:
Pere Barba, Marta Ligero, Cecilia Carpio, Maria Balaguer, Víctor Navarro Garcés, Sabela Bobillo, Francisco Beas, Pau Abrisqueta, Roser Sala, Francesc Bosch, Gloria Iacoboni, Marc Simo, Raquel Perez-Lopez
Publikováno v:
Blood. 140:3783-3784